De Novo Design of Miniprotein Binders Targeting the Leptin-Binding Site of the Leptin Receptor
In the authors' words
The leptin receptor (LEPR) regulates appetite, energy balance, glucose homeostasis, and neuroendocrine function and is closely associated with obesity, diabetes, and neurological disorders. Activation of LEPR signaling suppresses appetite and promotes energy expenditure, whereas impaired LEPR signaling and leptin resistance are commonly associated with obesity. Accordingly, modulation of LEPR signaling is a potential therapeutic strategy for obesity and related metabolic disorders. In this study, we report the de novo computational design of miniprotein binders targeting the leptin-binding site within the cytokine receptor homology 2 (CRH2) domain of LEPR. Computational screening and biochemical characterization identified the miniprotein binder Mini-19484, which adopted a stable -helical fold and exhibited enhanced resistance to proteolytic degradation. Mini-19484 bound the LEPR CRH2 domain with high affinity, with a dissociation constant (Kd) of 30 nM. Structural analysis of the predicted model and mutagenesis studies revealed that Arg18 of Mini-19484 serves as a critical interaction hotspot for LEPR binding. The predicted binding mode of Mini-19484 differed substantially from that of natural leptin, providing a distinct molecular scaffold for targeting the LEPR CRH2 domain. These findings provide a valuable framework for developing miniprotein-based therapeutics targeting LEPR.
Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.